Final ID: Sa909
Paradis Aidan, Paradis Norman, Gaddy David, Moodie Karen, Mader Timothy, Dufresne Alexandre, Couturier Christine, Dufresne Simon, Davis Daniel, Sims Christopher
A Phase 2 Study Evaluating the Effects of Mivelsiran, an Investigational RNA Interference Therapeutic, on Hemorrhagic and Nonhemorrhagic Manifestations of Cerebral Amyloid AngiopathyGreenberg Steven, Parikh Neal, Lee Jin-moo, Van Etten Ellis, Van Osch Matthias, Klijn Catharina, Sostelly Alexandre, Goteti Sasikiran, Sepehrband Farshid, Avbersek Andreja, Deering Robert